BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8020113)

  • 1. [Monoclonal antibodies to dystrophin in biopsy diagnosis of Duchenne and Becker progressive muscular dystrophies].
    Lukás Z; Foretová L; Vojtísková M; Dráber P; Hájek J
    Cesk Patol; 1994 May; 30(2):37-42. PubMed ID: 8020113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.
    Voit T; Haas K; Léger JO; Pons F; Léger JJ
    Am J Pathol; 1991 Nov; 139(5):969-76. PubMed ID: 1951635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
    Colomer Oferil J; Vila Torres J; Huezo Montoya C
    Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry.
    Oliveira AS; Gabbai AA; Schmidt B; Kiyomoto BH; Lima JG; Minetti C; Bonilla E
    Arq Neuropsiquiatr; 1992 Dec; 50(4):478-85. PubMed ID: 1309152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
    Ikeya K; Saito K; Yamauchi A; Kondo E; Komine S; Ikenaka H; Mishima M; Takahashi R; Harada T; Fukuyama Y
    No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of dystrophin in muscular diseases by two-dimensional gel electrophoresis using agarose gels in the first dimension.
    Hamano K; Takeya T; Iwasaki N; Okoshi N; Fukubayashi T; Kirinoki M; Yao Y; Hirabayashi T; Takita H
    Acta Neurol Belg; 1996 Jun; 96(2):102-7. PubMed ID: 8711982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of dystrophin with anti-peptide antibodies].
    Takeda A; Jimi T; Misugi N; Miyake S; Kumagai T; Nakamura Y; Wakayama Y
    Rinsho Byori; 1992 Sep; 40(9):953-8. PubMed ID: 1434031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of dystrophin-positive fibers in Duchenne and Becker muscular dystrophy.
    Taşdemir HA; Kotiloğlu E; Topaloğlu H; Kale G; Dinçer DP; Yalaz K; Renda Y
    Pediatr Pathol Lab Med; 1996; 16(4):583-90. PubMed ID: 9025855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of dystrophin in neuromuscular disorders.
    Wu CL; Chien YY
    J Formos Med Assoc; 1992 Apr; 91(4):438-42. PubMed ID: 1358314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dystrophin in the differentiation between Duchenne and Becker muscular dystrophies: an immunohistochemical study compared with clinical stage, serum enzymes and muscle biopsy].
    Werneck LC; Bonilla E
    Arq Neuropsiquiatr; 1990 Dec; 48(4):454-64. PubMed ID: 2094192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
    Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
    J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S; Sarkar C; Dinda AK; Maheshwari MC
    Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
    Slater CR; Nicholson LV
    J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
    Byers TJ; Neumann PE; Beggs AH; Kunkel LM
    Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of severe Becker muscular dystrophy diagnosed in early childhood--correlation between clinical severity and dystrophin testing].
    Ishikawa Y; Ishikawa Y; Sumitani S; Minami R
    No To Hattatsu; 1995 Jan; 27(1):53-7. PubMed ID: 7873253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.